Neurology

You are here

Trial Directory

Stroke, Critical Care & Neurohospitalist Program

ENRICH (Early MiNimally-invasive Removal of IntraCerebral Hemorrhage)

Status: Open for Enrollment

Principal Investigator: Santosh Murthy, MD

Phone: 212-746-6757

Read More

CREST-H (Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics)

Status: Open for Enrollment

Principal Investigator: Dana Leifer, MD

Phone: 212-746-6757

Read More

MOST-CA (Mechanisms Of ischemic STroke in CAncer patients)

Status: Open for Enrollment

Principal Investigator: Babak Navi, MD

Phone: 212-746-6757

Read More

CREST2 (Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial)

Status: Open for Enrollment

Principal Investigator: Dana Leifer, MD

Phone: 212-746-6757

Read More

ARCADIA (AtRial Cardiopathy and Antithrombotic Drugs in Prevention After Cryptogenic Stroke)

Status: Open for Enrollment

Principal Investigator: Hooman Kamel, MD

Phone: 212-746-6757

Read More

Parkinson's Disease & Movement Disorders Institute

BioFIND: Fox Investigation for New Discovery of Parkinson's Disease Biomarkers

Status: Open for Enrollment

Principal Investigator: Claire Henchcliffe, MD, D.Phil

Phone: (212) 746-2474

Read More

Biogen Parkinson's Disease Biomarker Imaging Study

Status: Open for Enrollment

Principal Investigator: Claire Henchcliffe, MD, D.Phil

Phone: 212-746-2474

Additional Investigator: P. David Mozley

Read More

N-acetylcysteine for neuroprotection in Parkinson's disease

Status: Open for Enrollment

Principal Investigator: Claire Henchcliffe, MD, D.Phil

Phone: (212) 746-2474

Additional Investigator: Dikoma Shungu

Judith Jaffe Multiple Sclerosis Center

Ascertaining the influence of Gilenya® (FTY720) on the innate immune burden in multiple sclerosis - Healthy Volunteers Needed

Status: Open for Enrollment

Principal Investigator: Susan Gauthier, DO, MPH

Phone: (646) 962-5736

Read More

Remyelination and preservation of neuronal integrity with natalizumab treatment

Status: Closed

Principal Investigator: Susan Gauthier, DO, MPH

Ascertaining the impact of natalizumab (Tysabri®) on the true inflammatory burden in Multiple Sclerosis

Status: Closed

Principal Investigator: Susan Gauthier, DO, MPH

Measuring active microglia in progressive multiple sclerosis

Status: Open for Enrollment

Principal Investigator: Susan Gauthier, DO, MPH

Phone: (646) 962-5736

Read More

Examination of serum, cerebrospinal fluid (CSF) and stool for exposure to bacterial toxins that target myelin and the blood brain barrier in Multiple Sclerosis (MS)

Status: Open for Enrollment

Principal Investigator: Timothy Vartanian, MD, PhD

STRIVE-A Multicenter, Observational, Open-Label, Single-Arm Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JCV Antibody Negative Patients

Status: Open for Enrollment

Principal Investigator: Jai Perumal, MD

Weill Cornell Multiple Sclerosis Database

Status: Open for Enrollment

Principal Investigator: Susan Gauthier, DO, MPH

Peripheral Neuropathy Center

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)

Status: Open for Enrollment

Principal Investigator: Norman Latov, MD, PhD

Phone: (646) 962-2149

Additional Cornell Investigator: Russell L. Chin, MD, Jennifer A. Langsdorf, MD

Read More

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)

Status: Open for Enrollment

Principal Investigator: Norman Latov, MD, PhD

Phone: (646) 962-2149

Additional Cornell Investigator: Russell L. Chin, MD, Jennifer A. Langsdorf, MD

Read More

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)

Status: Open for Enrollment

Principal Investigator: Norman Latov, MD, PhD

Phone: (646) 962-2149

Read More

Characteristics of Patients with Sensory Neuropathy Diagnosed with Abnormal Sweat Gland Nerve Density on Skin Biopsy

Status: Open for Enrollment

Principal Investigator: Russell L. Chin, MD

International Guillain-Barre Syndrome Outcome Study (IGOS): A prospective Inflammatory Neuropathy Consortium (INC) study on clinical and biological predictors of disease course and outcome in Guillain-Barre Syndrome (GBS)

Status: Open for Enrollment

Principal Investigator: Russell L. Chin, MD

Center for Sleep Medicine

Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea

Status: Open for Enrollment

Principal Investigator: Ana C. Krieger, MD, MPH

Weill Cornell Medicine Neurology 520 East 70th Street (at York Avenue) Starr Pavilion 607 New York, NY 10021 Phone: (212) 746-2596